This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v1.0.0: STU 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Official URL: http://hl7.org/fhir/uv/pddi/ValueSet/valueset-oxaprozin | Version: 1.0.0 | ||||
| Standards status: Informative | Computable Name: Valueset_oxaprozin | ||||
Copyright/Legal: (copyright expectations unknown) |
|||||
ValueSet containing drug identifiers for oxaprozin.
References
http://www.nlm.nih.gov/research/umls/rxnorm version Not Stated (use latest from terminology server)| Code | Display |
| 157381 | Daypro |
| 32613 | oxaprozin |
| 660767 | Oxaprozin potassium |
| 207243 | oxaprozin 600 MG Oral Tablet [Daypro] |
| 568030 | oxaprozin 600 MG [Daypro] |
| 368765 | oxaprozin Oral Tablet [Daypro] |
| 312132 | oxaprozin 600 MG Oral Tablet |
| 349188 | oxaprozin 600 MG Delayed Release Oral Capsule |
| 316413 | oxaprozin 600 MG |
| 373169 | oxaprozin Oral Tablet |
| 378275 | oxaprozin Delayed Release Oral Capsule |
| 1160122 | oxaprozin Oral Product |
| 1160123 | oxaprozin Pill |
| 1168832 | Daypro Oral Product |
| 1168833 | Daypro Pill |
Expansion from tx.fhir.org based on codesystem RxNorm version 03022026
This value set contains 15 concepts